Bita Esmaeli

Bita Esmaeli's AcademicInfluence.com Rankings

Bita Esmaeli

Medical

#3458

World Rank

#3927

Historical Rank

#507

USA Rank

Ophthalmology

#72

World Rank

#93

Historical Rank

USA Rank

medical Degrees

Download Badge

Medical

Bita Esmaeli's Degrees

Doctorate Medicine University of California, San Francisco
PhD Biomedical Sciences University of California, San Francisco

Why Is Bita Esmaeli Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Bita Esmaeli's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

The Immune Landscape of Cancer (2018) (2766)
Oncogenic Signaling Pathways in The Cancer Genome Atlas (2018) (1646)
Comprehensive Characterization of Cancer Driver Genes and Mutations (2018) (1360)
Phase I and pharmacokinetic study of ABI-007, a Cremophor-free, protein-stabilized, nanoparticle formulation of paclitaxel. (2002) (609)
Phase II study of weekly docetaxel and trastuzumab for patients with HER-2-overexpressing metastatic breast cancer. (2002) (571)
Pathogenic Germline Variants in 10,389 Adult Cancers (2018) (501)
Comprehensive Analysis of Alternative Splicing Across Tumors from 8,705 Patients (2018) (471)
Integrative Analysis Identifies Four Molecular and Clinical Subsets in Uveal Melanoma. (2017) (371)
Intervention Within Days for Some Orbital Floor Fractures: The White‐Eyed Blowout (1998) (286)
Integrative Analysis Identifies Four Molecular and Clinical Subsets in Uveal Melanoma. (2018) (276)
Uveal melanoma: From diagnosis to treatment and the science in between (2016) (226)
Metastatic tumors of the orbit and ocular adnexa (2007) (207)
Pan-Cancer Analysis of lncRNA Regulation Supports Their Targeting of Cancer Genes in Each Tumor Context (2018) (188)
Visual outcome and ocular survival after penetrating trauma. A clinicopathologic study. (1995) (184)
Successful treatment of Erdheim-Chester disease, a non–Langerhans-cell histiocytosis, with interferon-α (2005) (163)
Prognostic Value of the Staging System for Eyelid Tumors in the 7th Edition of the American Joint Committee on Cancer Staging Manual. (2017) (138)
Combination Small Molecule MEK and PI3K Inhibition Enhances Uveal Melanoma Cell Death in a Mutant GNAQ- and GNA11-Dependent Manner (2012) (138)
Outcomes in Patients with Adenoid Cystic Carcinoma of the Lacrimal Gland (2004) (134)
Patterns of regional and distant metastasis in patients with eyelid and periocular squamous cell carcinoma. (2004) (129)
Canalicular stenosis secondary to docetaxel (taxotere): a newly recognized side effect. (2001) (129)
Orbital and adnexal sarcoidosis. (2007) (129)
Patterns of regional and distant metastasis in patients with conjunctival melanoma: experience at a cancer center over four decades. (2001) (111)
Severe periorbital edema secondary to STI571 (Gleevec) (2002) (111)
Ocular side-effects associated with imatinib mesylate (Gleevec). (2003) (110)
Sentinel lymph node biopsy for sebaceous cell carcinoma and melanoma of the ocular adnexa. (2007) (109)
An Algorithmic Approach to Reconstructive Surgery and Prosthetic Rehabilitation after Orbital Exenteration (2009) (109)
American Joint Committee on Cancer classification predicts outcome of patients with lacrimal gland adenoid cystic carcinoma. (2009) (106)
Phase 3 study comparing the use of docetaxel on an every‐3‐week versus weekly schedule in the treatment of metastatic breast cancer (2008) (105)
Successful treatment of Erdheim-Chester disease, a non-Langerhans-cell histiocytosis, with interferon-alpha. (2005) (103)
Docetaxel secretion in tears: association with lacrimal drainage obstruction. (2002) (103)
Immunohistochemical evidence for estrogen receptors in meibomian glands. (2000) (100)
Meta–analyses of the association between Chlamydia psittaci and ocular adnexal lymphoma and the response of ocular adnexal lymphoma to antibiotics (2007) (96)
American Joint Committee on Cancer T category for eyelid sebaceous carcinoma correlates with nodal metastasis and survival. (2012) (95)
Change in Eyelid Carcinoma T Category With Use of the 8th Versus 7th Edition of the American Joint Committee on Cancer: Cancer Staging Manual. (2019) (94)
Experience With Sentinel Lymph Node Biopsy for Eyelid and Conjunctival Malignancies at a Cancer Center (2004) (93)
Conjunctival Lymphoma--An International Multicenter Retrospective Study. (2016) (79)
Blockage of the lacrimal drainage apparatus as a side effect of docetaxel therapy (2003) (78)
Treatment and outcomes for metastatic sebaceous cell carcinoma of the eyelid (2008) (78)
Survey of orbital tumors at a comprehensive cancer center in the United States (2011) (77)
Surgical Management of Locally Advanced Adenoid Cystic Carcinoma of the Lacrimal Gland (2006) (76)
Eyelid and ocular surface carcinoma: diagnosis and management. (2015) (76)
Sentinel lymph node biopsy for ocular adnexal melanoma: experience in 30 patients. (2009) (75)
Conjunctival melanoma. (2011) (73)
Natural killer/T-cell lymphoma with ocular and adnexal involvement. (2006) (73)
Prospective trial of targeted radioimmunotherapy with Y-90 ibritumomab tiuxetan (Zevalin) for front-line treatment of early-stage extranodal indolent ocular adnexal lymphoma. (2009) (71)
Long‐Term Results of Frontalis Suspension Using Irradiated, Banked Fascia Lata (1998) (70)
Outcomes of malignant tumors of the lacrimal apparatus (2011) (65)
Prevalence and nature of systemic involvement and stage at initial examination in patients with orbital and ocular adnexal lymphoma. (2007) (65)
Immunotherapy With Programmed Cell Death 1 Inhibitors for 5 Patients With Conjunctival Melanoma (2018) (64)
Sebaceous carcinoma: evidence-based clinical practice guidelines. (2019) (63)
Targeted Therapy for Orbital and Periocular Basal Cell Carcinoma and Squamous Cell Carcinoma (2013) (63)
Sentinel Lymph Node Biopsy for Eyelid and Conjunctival Tumors: What Have We Learned in the Past Decade? (2013) (62)
Ultra–low‐dose radiotherapy for definitive management of ocular adnexal B‐cell lymphoma (2017) (61)
Docetaxel-Induced Histologic Changes in the Lacrimal Sac and the Nasal Mucosa (2003) (61)
Ocular adnexal diffuse large B-cell lymphoma: a multicenter international study. (2015) (59)
Orbital Lymphoma-An International Multicenter Retrospective Study. (2019) (59)
Prognostic Factors for Survival in Malignant Melanoma of the Eyelid Skin (2000) (59)
Ocular findings in patients with solid tumours treated with the epidermal growth factor receptor tyrosine kinase inhibitor gefitinib (‘Iressa’, ZD1839) in Phase I and II clinical trials (2005) (59)
An Update on Tumors of the Lacrimal Gland. (2017) (58)
The Cancer Genome Atlas Project: An Integrated Molecular View of Uveal Melanoma. (2018) (57)
Sentinel Lymph Node Biopsy for Conjunctival Melanoma (2001) (57)
Feasibility of Preoperative Lymphoscintigraphy for Identification of Sentinel Lymph Nodes in Patients With Conjunctival and Periocular Skin Malignancies (2003) (54)
Introduction of the 7th edition eyelid carcinoma classification system from the American Joint Committee on Cancer-International Union Against Cancer staging manual. (2009) (52)
Next‐generation sequencing identifies high frequency of mutations in potentially clinically actionable genes in sebaceous carcinoma (2016) (51)
Canalicular stenosis secondary to weekly versus every-3-weeks docetaxel in patients with metastatic breast cancer. (2002) (51)
Fungal endophthalmitis in a tertiary care cancer center: a review of 23 cases (2008) (51)
Multidisciplinary Management of Lacrimal Sac/Nasolacrimal Duct Carcinomas (2013) (51)
Canalicular and nasolacrimal duct blockage: an ocular side effect associated with the antineoplastic drug S-1. (2005) (50)
Margins of Excision for Cutaneous Melanoma of the Eyelid Skin: The Collaborative Eyelid Skin Melanoma Group Report (2003) (49)
Successful treatment of cancer-associated retinopathy with alemtuzumab (2007) (49)
Interferon therapy for orbital infiltration secondary to Erdheim-Chester disease. (2001) (48)
Eye‐sparing multidisciplinary approach for the management of lacrimal gland carcinoma (2016) (48)
Periorbital Oedema and epiphora as ocular side effects of imatinib Mesylate (Gleevec) (2004) (48)
Outcomes after radiotherapy for squamous cell carcinoma of the eyelid (2008) (48)
Hedgehog Pathway Inhibition for Locally Advanced Periocular Basal Cell Carcinoma and Basal Cell Nevus Syndrome. (2015) (47)
Prospective study of incidence and severity of epiphora and canalicular stenosis in patients with metastatic breast cancer receiving docetaxel. (2006) (46)
Neoadjuvant chemotherapy–specific and overall treatment outcomes in patients with cutaneous angiosarcoma of the face with periorbital involvement (2008) (46)
GPNMB expression in uveal melanoma: a potential for targeted therapy (2009) (45)
Interferon-induced retinopathy in asymptomatic cancer patients. (2001) (45)
Regression of Kayser-Fleischer rings during oral zinc therapy: correlation with systemic manifestations of Wilson's disease. (1996) (45)
Endogenous endophthalmitis secondary to vancomycin-resistant enterococci infection. (2003) (45)
Postoperative Adjuvant External-Beam Radiation Therapy for Cancers of the Eyelid and Conjunctiva (2008) (44)
A Multidisciplinary Orbit-Sparing Treatment Approach That Includes Proton Therapy for Epithelial Tumors of the Orbit and Ocular Adnexa. (2016) (43)
Nasolacrimal duct obstruction associated with radioactive iodine therapy for thyroid carcinoma. (2003) (43)
Value of positron emission tomography in staging ocular adnexal lymphomas and evaluating their response to therapy. (2007) (43)
Histologic features of conjunctival melanoma predictive of metastasis and death (an American Ophthalmological thesis). (2012) (43)
Molecular Characteristics of Uveal Melanoma: Insights from the Cancer Genome Atlas (TCGA) Project (2019) (42)
Bone Invasion by Adenoid Cystic Carcinoma of the Lacrimal Gland: Preoperative Imaging Assessment and Surgical Considerations (2010) (42)
Immunotherapy for low-grade non-hodgkin secondary lymphoma of the orbit. (2002) (41)
Clinical Presentation and Treatment of Secondary Orbital Lymphoma (2002) (40)
Ocular adnexal lymphoma: validation of American Joint Committee on Cancer seventh edition staging guidelines (2014) (40)
Prognostic factors for local recurrence, metastasis and survival for sebaceous carcinoma of the eyelid: observations in 100 patients (2018) (40)
Social Challenges of Cancer Patients With Orbitofacial Disfigurement (2010) (40)
Mucinous Eccrine Adenocarcinoma of the Periocular Region (2006) (40)
Targeted monoclonal antibody therapy and radioimmunotherapy for lymphoproliferative disorders of the ocular adnexa (2008) (40)
Sentinel node biopsy as a tool for accurate staging of eyelid and conjunctival malignancies. (2002) (38)
Conjunctival melanoma with a positive sentinel lymph node. (2003) (38)
Parallel profiling of immune infiltrate subsets in uveal melanoma versus cutaneous melanoma unveils similarities and differences: A pilot study (2017) (38)
Immune Checkpoint Inhibitors for Treatment of Metastatic Melanoma of the Orbit and Ocular Adnexa. (2017) (38)
Canalicular stenosis secondary to weekly docetaxel: a potentially preventable side effect. (2002) (37)
Generation of customized orbital implant templates using 3-dimensional printing for orbital wall reconstruction (2018) (36)
Surgical treatment of canalicular stenosis in patients receiving docetaxel weekly. (2001) (36)
Sentinel lymph node biopsy for ocular adnexal melanoma (2017) (36)
Merkel cell carcinoma of the eyelid with a positive sentinel node. (2002) (35)
Sentinel Lymph Node Mapping for Patients With Cutaneous and Conjunctival Malignant Melanoma (2000) (35)
Epidermal growth factor receptor inhibitors for treatment of orbital squamous cell carcinoma. (2012) (35)
Conjunctival melanoma: local–regional control rates, and impact of high‐risk histopathologic features (2011) (35)
Receptor expression in orbital inflammatory syndromes and implications for targeted therapy. (2007) (34)
Merkel cell carcinoma of the head and neck: Favorable outcomes with radiotherapy (2016) (33)
Acellular Dermal Graft (AlloDerm) for Upper Eyelid Reconstruction After Cancer Removal (2009) (33)
Squamous Cell Carcinoma With Perineural Invasion Presenting as a Tolosa-Hunt–like Syndrome: A Potential Pitfall in Diagnosis (2000) (33)
Value of positron emission tomography/computed tomography in diagnosis and staging of primary ocular and orbital tumors. (2012) (33)
Ocular preservation with neoadjuvant vismodegib in patients with locally advanced periocular basal cell carcinoma (2018) (33)
Scleritis as the initial clinical manifestation of graft-versus-host disease after allogenic bone marrow transplantation. (2002) (31)
Evaluation and Management of Chemotherapy-Induced Epiphora, Punctal and Canalicular Stenosis, and Nasolacrimal Duct Obstruction. (2017) (31)
Distinct Biological Types of Ocular Adnexal Sebaceous Carcinoma: HPV-Driven and Virus-Negative Tumors Arise through Nonoverlapping Molecular-Genetic Alterations (2018) (30)
Orbital mass secondary to precursor T-cell acute lymphoblastic leukemia: a rare presentation. (2001) (30)
Extraocular Muscle Enlargement and Thyroid Eye Disease-like Orbital Inflammation Associated with Immune Checkpoint Inhibitor Therapy in Cancer Patients. (2019) (30)
Clinicopathological Features of Ocular Adnexal Mantle-Cell Lymphoma in an International Multicenter Cohort (2017) (30)
Management of Lacrimal Gland Carcinoma: Lessons From the Literature in the Past 40 Years (2016) (30)
Cancer Therapy : Preclinical Combination Small Molecule MEK and PI 3 K Inhibition Enhances Uveal Melanoma Cell Death in a Mutant GNAQ-and GNA 11-Dependent Manner (2012) (29)
Conjunctival Squamous Cell Carcinoma in the Anophthalmic Socket (2008) (29)
Current treatment of lacrimal gland carcinoma (2016) (29)
Outcomes of Periocular Reconstruction for Facial Nerve Paralysis in Cancer Patients (2007) (29)
Pilot Phase II Trial of Neoadjuvant Immunotherapy in Locoregionally Advanced, Resectable Cutaneous Squamous Cell Carcinoma of the Head and Neck (2021) (28)
Distinct pathways in the pathogenesis of sebaceous carcinomas implicated by differentially expressed microRNAs. (2015) (28)
The Role of Supraorbital Nerve Biopsy in Cutaneous Malignancies of the Periocular Region (2003) (28)
Positive sentinel node in sebaceous carcinoma of the eyelid. (2011) (28)
Ocular side effects associated with imatinib mesylate and perifosine for gastrointestinal stromal tumor. (2009) (27)
Systematic genomic and translational efficiency studies of uveal melanoma (2017) (26)
Lymphoma of the Eyelid - An International Multicenter Retrospective Study. (2017) (26)
International multicentre retrospective cohort study of ocular adnexal marginal zone B-cell lymphoma (2019) (26)
Association of Immunosuppression With Outcomes of Patients With Cutaneous Squamous Cell Carcinoma of the Head and Neck. (2019) (26)
Late choroidal metastasis secondary to papillary thyroid carcinoma. (2001) (25)
Impact of AJCC ‘T’ designation on risk of regional lymph node metastasis in patients with squamous carcinoma of the eyelid (2014) (25)
Ocular adnexal diffuse large B-cell lymphoma: local disease correlates with better outcomes (2010) (25)
Phase II study of neoadjuvant cemiplimab prior to surgery in patients with stage III/IV (M0) cutaneous squamous cell carcinoma of the head and neck (CSCC-HN) (2019) (24)
PD-L1/PD1 Expression, Composition of Tumor-Associated Immune Infiltrate, and HPV Status in Conjunctival Squamous Cell Carcinoma (2019) (24)
Cancer and facial disfigurement: reducing survivors' stigma in social interaction. (2012) (24)
Management of Perineural Invasion in Sebaceous Carcinoma of the Eyelid (2011) (24)
Expression of the Epidermal Growth Factor Receptor in Conjunctival Squamous Cell Carcinoma (2006) (23)
Imaging Characteristics of Dacryocystocele Diagnosed after Surgery for Sinonasal Cancer (2007) (23)
Merkel Cell Carcinoma of the Eyelid and Periocular Region (2014) (23)
Immune profiling of uveal melanoma identifies a potential signature associated with response to immunotherapy (2020) (22)
Mutational landscape of lacrimal gland carcinomas and implications for treatment (2016) (22)
Greater Tumor Thickness, Ulceration, and Positive Sentinel Lymph Node Are Associated With Worse Prognosis in Patients With Conjunctival Melanoma (2019) (22)
Conjunctival melanoma: New insights in tumour genetics and immunology, leading to new therapeutic options (2021) (22)
Ultra–low‐dose radiotherapy for definitive management of ocular adnexal B‐cell lymphoma (2018) (22)
Leiomyosarcoma of the Esophagus Metastatic to the Eyelid: A Clinicopathologic Report (2002) (22)
Loss of Epithelial p53 and αv Integrin Cooperate through Akt to Induce Squamous Cell Carcinoma yet Prevent Remodeling of the Tumor Microenvironment (2014) (22)
Targeting the Hedgehog Pathway for Locally Advanced and Metastatic Basal Cell Carcinoma. (2017) (21)
Eyelid Reconstruction (2017) (21)
Management of Radiation-Induced Severe Anophthalmic Socket Contracture in Patients With Uveal Melanoma (2012) (21)
Epidermal growth factor receptor (EGFR) expression in periocular and extraocular sebaceous carcinoma (2010) (21)
Number of excisions required to obtain clear surgical margins and prognostic value of AJCC T category for patients with eyelid melanoma (2014) (21)
Regional lymph node assessment for conjunctival melanoma: sentinel lymph node biopsy and positron emission tomography (2008) (20)
Management of excessive tearing as a side effect of docetaxel. (2005) (20)
Targeting EGFR and sonic hedgehog pathways for locally advanced eyelid and periocular carcinomas. (2014) (20)
Impact of Food and Drug Administration Approval of Vismodegib on Prevalence of Orbital Exenteration as a Necessary Surgical Treatment for Locally Advanced Periocular Basal Cell Carcinoma. (2019) (20)
Clinical Presentation and Anatomical Location of Orbital Plasmacytomas. (2017) (20)
Ophthalmic complications of targeted cancer therapy and recently recognized ophthalmic complications of traditional chemotherapy. (2014) (20)
Orbital rhabdomyosarcoma metastatic to the contralateral orbit: a case report. (2002) (19)
Squamous metaplasia of the canaliculi associated with 5-fluorouracil: a clinicopathologic case report. (2002) (19)
Outcomes of dacryocystorhinostomy in patients with head and neck tumors (2005) (19)
Advances in the Management of Malignant Tumors of the Eyelid and Conjunctiva: The Role of Sentinel Lymph Node Biopsy (2002) (19)
Eye-Preserving Surgery Followed by Adjuvant Radiotherapy for Lacrimal Gland Carcinoma: Outcomes in 37 Patients. (2018) (19)
Mohs micrographic surgery for eyelid sebaceous carcinoma: A multicenter cohort of 360 patients. (2019) (19)
Validation Study of the AJCC Cancer Staging Manual, Eighth Edition, Staging System for Eyelid and Periocular Squamous Cell Carcinoma (2019) (18)
Wilson's disease: presymptomatic patients and Kayser-Fleischer rings. (1996) (18)
High expression of PD-1 and PD-L1 in ocular adnexal sebaceous carcinoma (2018) (18)
Clinical value of magnetic resonance imaging and other baseline testing for conjunctival mucosa-associated lymphoid tissue lymphoma (2014) (18)
Imaging Features of Malignant Lacrimal Sac and Nasolacrimal Duct Tumors (2016) (17)
Ulcerative keratitis in gastrointestinal stromal tumor patients treated with perifosine. (2007) (17)
Ultrasound biomicroscopy for estimation of tumor thickness for conjunctival melanoma (2006) (17)
Viability of full‐thickness skin grafts used for correction of cicatricial ectropion of lower eyelid in previously irradiated field in the periocular region (2013) (17)
Preoperative radiation therapy in the management of recurrent orbital hemangiopericytoma. (2011) (17)
Correlation of American Joint Committee on Cancer T Category for Eyelid Carcinoma With Outcomes in Patients With Periocular Merkel Cell Carcinoma (2014) (16)
Outcomes of Dacryocystorhinostomy in Patients With Head and Neck Cancer Treated With High-Dose Radiation Therapy (2012) (15)
Epithelial, non-melanocytic and melanocytic proliferations of the ocular surface. (2016) (14)
Treatment of Benign Lymphoid Hyperplasia of the Orbit With Rituximab (2010) (14)
Epidermal Growth Factor Receptor P753S Mutation in Cutaneous Squamous Cell Carcinoma Responsive to Cetuximab-Based Therapy. (2016) (13)
Surgical resection of locally advanced granular cell tumor of the orbit. (2006) (13)
Epidemiology and Prognosis of Primary Periocular Sweat Gland Carcinomas. (2017) (13)
Expression of retinoid receptors in sebaceous cell carcinoma (2005) (13)
Feasibility of Using American Joint Committee on Cancer Classification Criteria for Staging Eyelid Carcinomas (2011) (12)
Prognostic accuracy of the seventh edition vs sixth edition of the American Joint Committee on Cancer tumor classification for adenoid cystic carcinoma of the lacrimal gland. (2012) (12)
Imaging Findings of Recurrent Tumors After Orbital Exenteration and Free Flap Reconstruction (2014) (12)
Does intra-arterial chemotherapy improve survival for lacrimal gland adenoid cystic carcinoma? (2014) (12)
Dasatinib-responsive mast cell neoplasms as initial presentation of chronic myelogenous leukemia in blast phase. (2011) (12)
Cellular blue nevi of the eyelid: A possible diagnostic pitfall. (2008) (12)
Cutaneous Eyelid Neoplasms as a Toxicity of Vemurafenib Therapy. (2015) (12)
Superior ophthalmic vein thrombosis in a patient with chronic myeloid leukemia receiving antifibrinolytic and thrombopoietin receptor agonist therapy. (2010) (12)
Diagnosis and management of malignant tumors of the eyelid, conjunctiva and orbit (2008) (12)
Orbital carcinomas treated with adjuvant intensity‐modulated radiation therapy (2016) (12)
Sclerosing polycystic adenosis of the lacrimal gland. (2013) (12)
Orbitofacial Metastatic Basal Cell Carcinoma: Report of 10 Cases. (2017) (12)
Eyelid and Periorbital Cutaneous Malignant Melanoma (2009) (12)
Regional nodal recurrence of sebaceous carcinoma of the caruncle 11 years after primary tumor resection. (2013) (11)
Primary intraocular ancient schwannoma: A case report and review of the literature (2014) (11)
Pathological Features and Clinical Course in Patients With Recurrent or Malignant Orbital Solitary Fibrous Tumor/Hemangiopericytoma. (2019) (11)
Canalicular stenosis as the underlying mechanism for epiphora in patients receiving weekly docetaxel. (2001) (11)
Surgical specimen handling for conjunctival melanoma: implications for tumor thickness determination and sentinel lymph node biopsy. (2006) (11)
Prognostic Factors for Orbital Exenteration, Local Recurrence, Metastasis, and Death From Disease in Conjunctival Squamous Cell Carcinoma. (2020) (11)
Malignant Mixed Tumor (Carcinoma Ex Pleomorphic Adenoma) of the Lacrimal Gland (2020) (10)
Epiphora and canalicular stenosis associated with adjuvant docetaxel in early breast cancer: is excessive tearing clinically important? (2013) (10)
Efficacy of Adjuvant and Neoadjuvant Therapies for Adult Orbital Sarcomas (2010) (10)
Facial Disfigurement, Stigma, and Cancer: Interaction Between Patients and Members of Secondary Groups (2012) (10)
Rates of Positive Findings on Positron Emission Tomography and Bone Marrow Biopsy in Patients With Ocular Adnexal Lymphoma. (2017) (10)
Non-incisional eyelid everting suture technique for treating lower lid epiblepharon (2018) (10)
Cutaneous Melanoma Metastatic to the Eyelid and Periocular Skin (2010) (9)
Prevalence and Severity of Ocular Surface Neoplasia in African Nations and Need for Early Interventions (2016) (9)
Rituximab Monotherapy Is Effective in Treating Orbital Necrobiotic Xanthogranuloma. (2017) (9)
Orbital and Ocular Adnexal Lymphoma (2015) (9)
Targeted Biological Drugs and Immune Check Point Inhibitors for Locally Advanced or Metastatic Cancers of the Conjunctiva, Eyelid, and Orbit. (2019) (8)
Sclerosing Sweat‐Duct Carcinoma (Malignant Syringoma) of the Upper Eyelid: A Patient Report With Immunohistochemical and Ultrastructural Analysis (1998) (8)
Marginal Keratitis Associated With Administration of Filgrastim and Sargramostim in a Healthy Peripheral Blood Progenitor Cell Donor (2002) (8)
Desmoplastic Small Round Cell Tumor Presenting as an Ocular Mass: Unusual Localization and Remarkable Surgical Approach (2017) (8)
Whole-exome sequencing for ocular adnexal sebaceous carcinoma suggests PCDH15 as a novel mutation associated with metastasis (2020) (7)
Erratum: Experience with sentinel lymph node biopsy for eyelid and conjunctival malignancies at a cancer center (Ophthalmic Plastic and Reconstructive Surgery (2004) 20 (291-295)) (2005) (7)
Lymphoma of the lacrimal gland - An International Multicenter Retrospective Study. (2020) (7)
Clinical Course of Preseptal and Orbital Cellulitis in 50 Immunocompromised Patients with Cancer. (2017) (7)
Estimation of yttrium-90 Zevalin tumor-absorbed dose in ocular adnexal lymphoma using quantitative indium-111 Zevalin radionuclide imaging (2009) (7)
Retinoid Receptor Subtypes in Sebaceous Cell Carcinoma of the Eyelid (2005) (7)
Prevalence of a Histologic Change of Ocular Adnexal Lymphoma in Patients With a History of Lymphoma. (2019) (7)
Receptor expression in orbital inflammatory syndromes and implications for targeted therapy (Tissue Antigens (2007) 70, (105-109)) (2008) (6)
Eyelid and Conjunctival Neoplasms (2020) (6)
Ultra–low‐dose radiotherapy for definitive management of ocular adnexal B‐cell lymphoma (2019) (6)
Idiopathic inflammation of the orbit and contiguous structures. (2012) (6)
Prognostic factors for local recurrence and survival and impact of local treatments on survival in lacrimal gland carcinoma (2020) (6)
Predictors of Local Recurrence for Eyelid Sebaceous Carcinoma: Questionable Value of Routine Conjunctival Map Biopsies for Detection of Pagetoid Spread. (2019) (6)
Three-Dimensional Multidetector CT for Anatomic Evaluation of Orbital Tumors (2013) (6)
Disseminated conjunctival melanoma. (2004) (6)
Primary orbital melanoma in association with cellular blue nevus. (2014) (6)
PD-L 1 / PD 1 Expression , Composition of Tumor-Associated Immune Infiltrate , and HPV Status in Conjunctival Squamous Cell Carcinoma (2019) (6)
Treatment Challenges with Benign Bone Tumors of the Orbit (2015) (6)
Second-line 90Yttrium-ibritumomab tiuxetan (Zevalin) in a patient with conjunctival mucosa-associated lymphoid tissue lymphoma refractory to rituximab. (2012) (6)
Disease recurrence after intraarterial chemotherapy in 2 patients with adenoid cystic carcinoma of lacrimal gland. (2013) (5)
Proton Therapy for Head and Neck Cancer: A 12-Year, Single-Institution Experience (2021) (5)
Inverted Papilloma of the Orbit and Nasolacrimal System. (2020) (5)
Intraoperative lagophthalmos formula for levator resection in congenital ptosis (2018) (5)
Trends in hepatocyte growth factor, insulin-like growth factor 1, thyroid-stimulating hormone, and leptin expression levels in uveal melanoma patient serum and tumor tissues: correlation to disease progression (2017) (5)
Primary Orbital Liposarcoma Misdiagnosed as Thyroid Associated Orbitopathy (2012) (5)
Immune Checkpoint Inhibitor Therapy as an Eye-Preserving Treatment for Locally Advanced Conjunctival Melanoma. (2020) (5)
Growth factor receptor expression in orbital lymphangioma: possible therapeutic implications (2004) (5)
Multidisciplinary management of primary adenoid cystic carcinoma of the eyelid with perineural invasion. (2013) (5)
Carcinoid Tumors of the Orbit and Ocular Adnexa. (2020) (5)
Durable response to chemotherapy for recurrent squamous cell carcinoma of the cheek with perineural spread. (2009) (4)
Association of T and N Categories of the American Joint Commission on Cancer, 8th Edition, With Metastasis and Survival in Patients With Orbital Sarcoma. (2020) (4)
Prospective study of incidence and severity of epiphora and canalicular stenosis in patients with metastatic breast cancer receiving docetaxel. (2006) (4)
Indications and limitations of vismodegib for basal cell carcinoma. (2014) (4)
Analysis of αv integrin protein expression in human eyelid and periorbital squamous cell carcinomas (2011) (4)
Inclusion of Histologic Ulceration and Tumor Thickness in Future American Joint Committee on Cancer T Category Definitions for Conjunctival Melanoma. (2019) (4)
Orbital and optic chiasmal extension of uveal melanoma. (2004) (4)
Treatment patterns and outcomes of palliative systemic therapy in patients with salivary duct carcinoma and adenocarcinoma, not otherwise specified (2021) (3)
Immune checkpoint inhibitors for treatment of periorbital squamous cell carcinoma (2021) (3)
Frequency and clinical course of residual orbital masses after treatment of orbital rhabdomyosarcoma. (2021) (3)
Intravitreal hemoglobin spherulosis: a rare complication of subretinal hemorrhage. (2002) (3)
Commentary on "sentinel node biopsy for orbital and ocular adnexal tumors" (2001) (3)
Congenital Cystic Eye In Utero: Novel Prenatal Magnetic Resonance Imaging Findings (2015) (3)
The practice patterns in the management of sebaceous carcinoma of the eyelid in the Asia Pacific region (2019) (3)
Eyelid Reconstruction: An Oculoplastic Surgeon's Perspective (2001) (3)
MRI Findings of Myocutaneous and Fasciocutaneous Flaps Used for Reconstruction of Orbital Exenteration Defects (2014) (3)
Outcomes after eye‐sparing surgery vs orbital exenteration in patients with lacrimal gland carcinoma (2020) (3)
Multidisciplinary Management of Orbital Metastasis and Survival Outcomes (2021) (3)
Lymphoepitheliomalike carcinoma of the orbit. (2001) (3)
Eyelid and Ocular Adnexal Reconstruction (2020) (3)
Desmoplastic Melanoma of the Periorbital Region. (2017) (3)
Perineural Tumor Spread Along the Nasociliary Branch of the Ophthalmic Nerve: Imaging Findings (2013) (3)
Uveal Melanoma—Molecular Basis and Potential Treatment Targets (2011) (3)
Malignant mixed tumor of the lacrimal gland in a teenager. (2010) (3)
Squamous cell carcinoma with perineural spread (multiple letters) (2001) (3)
Management of Primary Eyelid Cancers (2010) (3)
Lacrimal Gland Carcinoma (2016) (2)
Update on sebaceous neoplasia: the morphologic spectrum and molecular genetic drivers of carcinoma (2019) (2)
Outcomes of orbital exenteration for craniofacial lesions (2021) (2)
Primary Orbital Cancers in Adults (2010) (2)
Reply: The Value of Secondary Intention Healing in Eyelid Reconstruction: Response to Recent CME Article by Chang, Esmaeli, and Butler - Content Needs to be Evidence-Based. (2018) (2)
Secondary Orbital Tumors Extending from Ocular or Periorbital Structures (2010) (2)
Re: "Upper and lower system nasolacrimal duct stenosis secondary to paclitaxel". (2009) (2)
Primary disease sites and patterns of spread in cases of neurolymphomatosis in the orbit associated with lymphoma (2021) (2)
Prospective collection of data using the 7th edition of the AJCC Cancer Staging Manual for cancers of the eyelid, orbit, and conjunctiva. (2011) (2)
Oculoplastic Complications of Cancer Therapy (2020) (2)
Re: "American Joint Committee on Cancer (AJCC) clinical classification predicts conjunctival melanoma outcomes". (2013) (2)
Targeting Genetic Aberrations in Uveal Melanoma (2010) (2)
Identification of Docetaxel in Tears from Patients with Metastatic Breast Cancer (2002) (2)
A 66-year-old woman with extensive conjunctival melanosis. (2014) (2)
Extrathyroidal Manifestations of Thyroid Disease: Graves Eye Disease. (2021) (2)
Sentinel lymph node biopsy is not relevant to perineural invasion for eyelid melanomas. (2008) (1)
A 60-year-old woman with an asymptomatic left lacrimal gland mass found incidentally. (2017) (1)
Rituximab and Yttrium-90 Ibritumomab Tiuxetan Radioimmunotherapy May Be Feasible Options in Patients with Low-Grade Lymphoma of the Orbit. (2005) (1)
Targeting IGF-1R In Uveal Melanoma Cells (2012) (1)
Periocular Ecchymoses in Neuroblastoma Metastatic to the Orbit. (2018) (1)
Primary Ewing's sarcoma with orbit involvement: Survival and visual outcomes after eye‐sparing multidisciplinary management in eight patients (2021) (1)
Eyelid Carcinoma in Patients with Systemic Lymphoma (2010) (1)
Primary Signet Ring Cell/Histiocytoid Carcinoma of the Eyelid: Clinicopathologic Analysis with Evaluation of the E-Cadherin/β-Catenin Complex and Associated Genetic Alterations (2021) (1)
GNAQ/11 Mutant Dependent Uveal Melanoma Sensitivity to MEK and PI3K Inhibitors (2011) (1)
Erratum to: Ultra-low-dose radiotherapy for definitive management of ocular adnexal B-cell lymphoma: Low-dose radiotherapy for adnexal b-cell lymphoma (Head & Neck, (2017), 39, 6, (1095-1100), 10.1002/hed.24717) (2019) (1)
Squamous Cell Carcinoma of the Caruncle. (2015) (1)
Ophthalmology as a specialty at comprehensive cancer centers in the United States. (2008) (1)
Outcomes and Patterns of Recurrence of Orbital Carcinomas Treated With IMRT (2013) (1)
Melanoma-Associated Retinopathy: A Harbinger of Recurrence for Cutaneous Melanoma (2001) (1)
Erratum: Patterns of regional and distant metastasis in patients with eyelid and periocular squamous cell carcinoma (Ophthalmology (2004) 111 (2137-2143)) (2005) (1)
Reply re: "Malignant Mixed Tumor (Carcinoma Ex Pleomorphic Adenoma) of the Lacrimal Gland". (2021) (1)
Melanocytic Lesions of the Eyelid and Ocular Adnexa (2020) (1)
Erratum to: Ultra–low-dose radiotherapy for definitive management of ocular adnexal B-cell lymphoma (Head Neck, (2017), 39, (1095–1100), 10.1002/hed.24717) (2018) (1)
Management of Conjunctival Neoplasms (2010) (1)
Early Topical Steroid Treatment for Grade IV Acute Ocular Graft vs. Host Disease (GVHD) with Corneal Epithelial Sloughing (2003) (1)
Specific location of ocular adnexal lymphoma and mortality: an international multicentre retrospective study (2022) (1)
Sentinel Lymph Node Biopsy for Conjunctival and Eyelid Malignancies (2006) (1)
Intravitreal hemoglobin spherulosis (2002) (1)
Re: "Sentinel lymph node biopsy in patients with conjunctival and eyelid cancers: experience in 17 patients". (2012) (1)
Targeted and Immune Therapy for Periocular and Orbital Malignancies (2019) (1)
Reply: Defining the Role of Secondary Intention Healing in Full-Thickness Lid Margin Defects. (2018) (1)
Oculoplastic Abstracts. (2020) (1)
Acute Orbital Syndrome in Herpes Zoster Ophthalmicus (2014) (1)
Eyelid Malposition: Unique Scenarios in Cancer Patients (2010) (1)
Reconstructive Surgery for Eyelid Defects (2010) (1)
Surgical and Ophthalmologic Outcomes of Reconstruction in Patients Treated With Eye-Sparing Surgery and Radiation Therapy for Tumors of the Lacrimal Drainage Apparatus (2021) (0)
Cancer generated facial disfigurement: Ethnicity, culture and social challenges (2010) (0)
Immunotherapy for Low-Grade Non-Hodgkin’s Lymphoma of the Orbit (2003) (0)
Metastatic Orbital Lesions: Breast Cancer (2021) (0)
Oculoplastics Abstracts (2018) (0)
Graves’ Eye Disease: Clinical and Radiological Diagnosis (2023) (0)
The Current State of Occuplastics in Oncology (2014) (0)
Surgery Followed by Cornea-Sparing Treatment Approach with Proton Therapy Reduces Orbital Exenteration for Cancer Patients with Periorbital Malignancies (2019) (0)
Management and Treatment Outcomes for Metastatic Sebaceous Cell Carcinoma of the Eyelid (2007) (0)
Multi-disciplinary Management Of Eyelid Merkel Cell Carcinoma (2012) (0)
Clinical Presentation and Management of Nasopharyngeal Carcinoma Invading the Orbit (2011) (0)
Loss of alpha-v integrin and p53 Cooperate to Induce Skin Squamous Cell Carcinomas (2011) (0)
Fresh tissue harvest and histopathologic processing of uveal melanoma specimens: Implications for basic research and patient care (2005) (0)
Interaction of Cancer Patients with Orbitofacial Disfigurement and Secondary Groups (2009) (0)
Benign (Reactive) Lymphoid Hyperplasia and Lymphoma (2021) (0)
Correction: Pilot Phase II Trial of Neoadjuvant Immunotherapy in Locoregionally Advanced, Resectable Cutaneous Squamous Cell Carcinoma of the Head and Neck. (2022) (0)
Orbital and periocular complications in patients with sinonasal tumours with orbital invasion (2023) (0)
Microphthalmia With Orbital Cyst: Features Unique to Adult Presentation (2007) (0)
HEAD & NECK Imaging Features ofMalignant Lacrimal Sac and Nasolacrimal Duct Tumors (2016) (0)
Central Serous Retinopathy in Cancer Patients (2012) (0)
Rituximab and yttrium-90 ibritumomab tiuxetan radioimmunotherapy as treatment options in patients with indolent lymphoma of the orbit. (2016) (0)
Clinical Outcomes and Histopathologic Features of Orbital Hemangiopericytoma/ Solitary Fibrous Tumors (2017) (0)
Abstract A27: Analyses of the level of liver borne growth factors, IGF-1 and HGF in metastatic and non-metastatic uveal melanoma patient serum: Correlation with outcome (2015) (0)
Ocular oncology: diagnosis and management of malignant intraocular tumors (2006) (0)
Visual outcome and ocular complications in patients with lacrimal gland carcinoma after eye-sparing surgery and adjuvant radiation therapy (2022) (0)
Characteristics and Survival Outcomes of Second Primary Cancers in Long-term Retinoblastoma Survivors (2021) (0)
Lacrimal Gland Tumors (2010) (0)
CANCER MANAGEMENT CONTROVERSY Ophthalmology as a Specialty at Comprehensive Cancer Centers in the United States (2008) (0)
Sentinel Lymph Node Biopsy for Eyelid and Conjunctival Malignancies (2019) (0)
Ki67 Proliferation Index as a Prognostic Factor in Ocular Adnexal Lymphoma (2013) (0)
Pediatric Idiopathic Orbital Inflammation (2013) (0)
Interferon-induced retinopathy in asymptomatic cancer patients: Author reply (2002) (0)
Desmoplastic Melanoma of the Periocular Region (2017) (0)
The 5th edition of the World Health Organization Classification of Tumours of the Eye and Orbit (2023) (0)
Identifying malignant eyelid tumors (2016) (0)
Response Adapted Ultra Low Dose Radiation Therapy for the Definitive Management of Orbital Indolent B-Cell Lymphoma (2022) (0)
Phase II Trial of Response Adapted Ultra Low Dose (ULD) Orbital Radiation Therapy for Indolent B Cell Lymphoma (2021) (0)
Identification of Novel Serum Proteins in Patients with Metastatic Uveal Melanoma Using Two-dimensional Gel Electrophoresis Coupled with Tandem Mass Spectrometry (2002) (0)
Pleomorphic Adenoma of the Lacrimal Gland (2021) (0)
Ophthalmic Emergencies in Cancer Patients (2021) (0)
International review of orbital diffuse large B cell lymphoma (2008) (0)
Abstract A1-15: Systematic genomic characterization of uveal melanoma (2015) (0)
Outcomes of dacrocystorhinostomy in patients with head and neck tumors. (2004) (0)
Orbital Extension of Tumors from the Paranasal Sinuses: Squamous Cell Carcinoma (2021) (0)
Proton Radiation as a Component of Multidisciplinary Orbit Sparing Treatment for Periorbital Tumors (2015) (0)
Reply to Drs. C.N.S. Soparkar and J.R. Patrinely’s Letter on Squamous Cell Carcinoma with Perineural Spread (2001) (0)
Lymphomas of the Ocular Adnexa (2018) (0)
Blockage of the Lacrimal Drainage Apparatus as a Side Effect of Docetaxel (Taxotere) Therapy: Clinical, Experimental, and Histopathologic Observations in over 150 Patients (2005) (0)
Low dose 4 Gy Orbital Radiation for Therapy of Indolent B-Cell Lymphoma of the Ocular Adnexa (2015) (0)
Long-term Outcomes of Globe-Preserving Surgery with Proton Beam Radiation for Adenoid Cystic Carcinoma of the Lacrimal Gland. (2019) (0)
Orbital Cellulitis in Cancer Patients (2018) (0)
Targeting c-Met/HGF Pathway In Uveal Melanoma Cells (2011) (0)
Lacrimal Gland Carcinoma: Primary (2021) (0)
Reply re: "Prognostic Factors for Orbital Exenteration, Local Recurrence, Metastasis, and Death From Disease in Conjunctival Squamous Cell Carcinoma". (2021) (0)
Glaucoma Drainage Device Giant Orbital Reservoir Formation Mimicking Orbital Cyst. (2022) (0)
Oculoplastic Abstracts. (2020) (0)
P63 expression in eyelid squamous cell carcinoma (2022) (0)
Reply re: "Efficacy of adjuvant and neoadjuvant therapies for adult orbital sarcomas" (2011) (0)
Long-term outcomes of a phase II trial of neoadjuvant immunotherapy for advanced, resectable cutaneous squamous cell carcinoma of the head and neck (CSCC-HN). (2022) (0)
Sentinel Lymph Node Biopsy for Conjunctival and Ocular Adnexal Tumors (2019) (0)
Analysis of v Integrin Expression in Human Conjunctiva, Eyelid, and Head and Neck Squamous Cell Carcinoma (2008) (0)
Nasolacrimal Duct Obstruction and Lacrimal Surgery in Cancer Patients (2010) (0)
Squamous Cell Carcinoma of Anophthalmic Socket in Patients With Chronic Ocular Prosthesis Use (2007) (0)
The combined profunda artery perforator-gracilis flap for immediate facial reanimation and resurfacing of the radical parotidectomy defect. (2022) (0)
Analyzing v Integrins in Conjunctival and Eyelid Squamous Cell Carcinoma (2009) (0)
Cell Surface Marker Expression in Fibroadiopose Tissue in Patients With Graves Orbitopathy (2009) (0)
Sentinel Lymph Node Assessment and Biopsy for Eyelid and Conjunctival Malignancies (2014) (0)
Re: Freitag et al.: Ophthalmic Technology Assessment: Sentinel lymph node biopsy for eyelid and conjunctival malignancy: a report by the American Academy of Ophthalmology (Ophthalmology. 2020;127:1757-1765). (2021) (0)
Metastatic Orbital Tumors (2010) (0)
Essentials of Ophthalmic Oncology, Arun D. Singh MD, Bertil E. Damato MD, PhD, FRCOphth, Jacob Pe'er MD, A. Linn Murphree MD, Julian D. Perry MD (Eds.). Slack Incorporated, Thorofare: New Jersey (2009), 258 pp, $89.95, ISBN: 978-1-55642-917-0 (2010) (0)
Update on Immune Checkpoint Inhibitors for Conjunctival Melanoma (2022) (0)
Comprar Ophthalmic Oncology | Esmaeli, Bita | 9781441903730 | Springer (2009) (0)
Head and Neck Adenoid Cystic Carcinoma: Focus on Outcomes of Intensity Modulated Proton Therapy (2019) (0)
Molecular Pathology: Poster#244 MUTATIONAL LANDSCAPE OF LACRIMAL GLAND CARCINOMAS AND IMPLICATIONS FOR TREATMENT (2014) (0)
A Novel Mouse Model to Study the Pathogenesis of Eyelid Squamous Cell Carcinoma (2007) (0)
Inflammatory Orbital Pseudotumor with involvement of Contiguous Periorbital Structures (2011) (0)
Treatment patterns and systemic therapy outcomes for patients with salivary duct carcinoma and adenocarcinoma NOS. (2021) (0)
Experience with sentinel lymph node biopsy for eyelid and conjunctival malignancies (2004) (0)
Non-surgical Drug Therapy for Locally Advanced Periocular Cancer (2016) (0)
Surgical specimen handling for conjunctival melanoma: Implications for local control, tumor thickness, and sentinel lymph node biopsy (2005) (0)
Oculoplastic Abstracts. (2020) (0)
2416 : Radiation Therapy for Squamous Cell Carcinoma of the Eyelid (2006) (0)
Orbital Positron Emission Tomography/Computed Tomography (PET/CT) (2021) (0)
Surgical Management of Adenoid Cystic Carcinoma of the Lacrimal Gland (2004) (0)
Patterns of local recurrence, regional nodal and distant metastasis, and survival after globe preserving surgery for conjunctival and eyelid melanomas (2008) (0)
Metastatic Orbital Lesions: Melanoma (2021) (0)
Kayser-Fleischer rings Wilson's disease: presymptomatic patients and (1997) (0)
Lacrimal and Canalicular Toxicity (2010) (0)
RAS Mutations Coexist with PIK3CA and MET Mutations in Lacrimal Gland Epithelial Neoplasms (2013) (0)
Differential Diagnosis of Malignant Tumors of the Lacrimal Sac (2021) (0)
Multifocal recurrence of pleomorphic adenoma of the lacrimal gland (2022) (0)
Oral Doxycycline for Mild Thyroid Eye Disease. (2022) (0)
Lacrimal Gland Prolapse and Dacryops (2021) (0)
Targeted Therapy in the Treatment of Orbital and Periorbital Malignancies (2010) (0)
Phase I and Pharmacokinetic Study of ABI-007 , a Cremophor-free , Protein-stabilized , Nanoparticle Formulation of Paclitaxel 1 (2002) (0)
Metastatic Orbital Lesions: Lung Cancer, Prostate Cancer, and Renal Cell Carcinoma (RCC) (2021) (0)
Experience with sentinel lymph node biopsy for eyelid and conjunctival malignancies. (2004) (0)
Sentinel Lymph Node Biopsy for Conjunctival and Eyelid Tumors (2020) (0)
Special Considerations for Periocular Basal Cell Carcinoma (2019) (0)
Management of Periorbital Edema and Epiphora: Common Ocular Side Effects of Imatinib Mesylate (Gleevec) (2004) (0)
Social interaction and stigmatization of cancer patients with orbitofacial disfigurement. (2016) (0)
Upper Eye Lid Reconstruction with Acellular Dermal Graft (AlloDerm) in Cancer Patients (2007) (0)
Recurrent Pleomorphic Adenoma of the Lacrimal Gland (RLGPA) (2021) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Bita Esmaeli?

Bita Esmaeli is affiliated with the following schools:

MD Anderson Cancer Center
University of Toronto
University of California, San Francisco

Bita Esmaeli's Academic­Influence.com Rankings